Exploring Individual Variability in Drug-Induced Liver Injury (DILI) Responses through Metabolomic Analysis. [PDF]
Moreno-Torres M +4 more
europepmc +1 more source
Drug-induced liver injury (DILI) ascribed to non-steroidal anti-inflammatory drugs (NSAIDs) in the USA-Update with genetic correlations. [PDF]
Bonkovsky HL +11 more
europepmc +1 more source
Delayed drug-induced liver injury (DILI) and flare of chronic plaque psoriasis secondary to lisinopril use. [PDF]
Jarman GL, Webb GJ.
europepmc +1 more source
A case report of a drug-induced liver injury (DILI) caused by multiple antidepressants with causality established by the updated Roussel Uclaf causality assessment method (RUCAM) and in vitro testing. [PDF]
González-Muñoz M +8 more
europepmc +1 more source
A computational study to identify Sesamol derivatives as NRF2 activator for protection against drug-induced liver injury (DILI). [PDF]
Mili A +3 more
europepmc +1 more source
Novel biomarkers for potential risk stratification of drug induced liver injury (DILI): A narrative perspective on current trends. [PDF]
Danjuma MI +3 more
europepmc +1 more source
A double-blinded randomized controlled trial of silymarin for the prevention of antituberculosis drug-induced liver injury [PDF]
Abhasnee Sobhonslidsuk +5 more
core +1 more source
Dyslipidemia is a Risk Factor for the Incidence and Severity of Drug-Induced Liver Injury (DILI): A Retrospective Population-Based Study in China. [PDF]
Li X, Wang L, Li D, Niu J, Gao P.
europepmc +1 more source
Terbinafine-induced liver injury with isolated serum alkaline phosphatase elevation: A case report and literature review. [PDF]
Liu YH, Guo Y, Xu H, Feng H, Pan F.
europepmc +1 more source
Elevated Polyreactive Immunoglobulin G in Immune-Mediated Liver Injuries With the Need for Immunosuppressive Therapy. [PDF]
Kirchner T +18 more
europepmc +1 more source

